Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells.
Growth of vascular smooth muscle cells (VSMC) plays an important role in the pathogenesis of atherosclerosis and hypertension. Lysophosphatidic acid (LPA), a natural phospholipid is thought to be an important VSMC mitogen and has recently been suggested to play an important role in the development of vascular disease. In the present study, we describe the effects of LPA on intracellular signalling pathways in VSMC. LPA (5 micrograms/ml) induced an increase of cytosolic free calcium concentration ([Ca2+]i) in the presence and absence of extracellular Ca2+ and markedly stimulated the Na+/H+ exchanger. LPA dose-dependently caused a stimulation of the 42-kDa mitogen-activated protein kinase (MAP kinase) isoform with a maximum at 5 min. Also, LPA induced a 5-fold increase in [3H]thymidine incorporation into cell DNA above the basal value, as well as a 42% increase in cell number. Pretreatment of VSMC with pertussis toxin (PTX) (100 ng/ml) for 24 h markedly blunted the LPA-dependent intracellular signalling transduction including the increase in [Ca2+]i, activation of the Na+/H+ exchanger, activation of MAP kinase and the increase in cell DNA synthesis. These findings demonstrate that the effects of LPA on intracellular signalling transduction pathway as well as on VSMC growth are mediated by PTX-sensitive guanosine triphosphate (GTP) binding protein (Gi protein).
Seewald
S
S
Medizinische Universitäts-Poliklinik, Bonn, Germany.
Sachinidis
A
A
Düsing
R
R
Ko
Y
Y
Seul
C
C
Epping
P
P
Vetter
H
H
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003600:Cytosol / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D006863:Hydrogen-Ion Concentration; D015151:Immunoblotting; D008246:Lysophospholipids / Q000494:pharmacology*; D020929:Mitogen-Activated Protein Kinase Kinases; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000502:physiology*; D037342:Pertussis Toxin; D010766:Phosphorylation; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D011921:Rats, Inbred WKY; D015398:Signal Transduction / Q000187:drug effects*; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D008246:Lysophospholipids; D017923:Sodium-Hydrogen Exchangers; D010566:Virulence Factors, Bordetella; D004247:DNA; D037342:Pertussis Toxin; D011494:Protein Kinases; D020929:Mitogen-Activated Protein Kinase Kinases; D002118:Calcium